Biocryst Pharmaceuticals (BCRX) Payables: 2010-2014
Historic Payables for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $32.8 million.
- Biocryst Pharmaceuticals' Payables fell 88.28% to $3.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $45.8 million, marking a year-over-year decrease of 34.77%. This contributed to the annual value of $32.8 million for FY2014, which is 686.99% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Payables stood at $32.8 million for FY2014, which was up 686.99% from $4.2 million recorded in FY2013.
- Over the past 5 years, Biocryst Pharmaceuticals' Payables peaked at $32.8 million during FY2014, and registered a low of $2.5 million during FY2011.
- Over the past 3 years, Biocryst Pharmaceuticals' median Payables value was $4.2 million (recorded in 2013), while the average stood at $13.7 million.
- Its Payables has fluctuated over the past 5 years, first slumped by 69.55% in 2011, then surged by 686.99% in 2014.
- Over the past 5 years, Biocryst Pharmaceuticals' Payables (Yearly) stood at $8.2 million in 2010, then plummeted by 69.55% to $2.5 million in 2011, then skyrocketed by 59.15% to $4.0 million in 2012, then rose by 5.03% to $4.2 million in 2013, then skyrocketed by 686.99% to $32.8 million in 2014.